72 related articles for article (PubMed ID: 11586036)
1. Microsatellite instability, expression of hMSH2 and hMLH1 and HPV infection in cervical cancer and their clinico-pathological association.
Chung TK; Cheung TH; Wang VW; Yu MY; Wong YF
Gynecol Obstet Invest; 2001; 52(2):98-103. PubMed ID: 11586036
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of microsatellite instability determined by immunohistochemical staining of MSH2 and MLH1 in sporadic T3N0M0 colon cancer.
Parc Y; Gueroult S; Mourra N; Serfaty L; Fléjou JF; Tiret E; Parc R
Gut; 2004 Mar; 53(3):371-5. PubMed ID: 14960518
[TBL] [Abstract][Full Text] [Related]
3. Genetic, immunohistochemical, and clinical features of medullary carcinoma of the pancreas: A newly described and characterized entity.
Wilentz RE; Goggins M; Redston M; Marcus VA; Adsay NV; Sohn TA; Kadkol SS; Yeo CJ; Choti M; Zahurak M; Johnson K; Tascilar M; Offerhaus GJ; Hruban RH; Kern SE
Am J Pathol; 2000 May; 156(5):1641-51. PubMed ID: 10793075
[TBL] [Abstract][Full Text] [Related]
4. Tumor microsatellite instability in early onset gastric cancer.
Bacani J; Zwingerman R; Di Nicola N; Spencer S; Wegrynowski T; Mitchell K; Hay K; Redston M; Holowaty E; Huntsman D; Pollett A; Riddell R; Gallinger S
J Mol Diagn; 2005 Oct; 7(4):465-77. PubMed ID: 16237216
[TBL] [Abstract][Full Text] [Related]
5. Role of MLH1 and MSH2 deficiency in the development of tumorigenesis and chemo-tolerance of cervical Carcinoma: Clinical implications.
Dutta P; Pal D; Roy A; Mandal RK; Panda CK
Gene; 2023 Dec; 888():147746. PubMed ID: 37657688
[TBL] [Abstract][Full Text] [Related]
6. Is HPV-negative cervical carcinoma a different type of cervical cancer?
Kulhan M; Bilgi A; Avci F; Ucar MG; Celik C; Kulhan NG
Eur Rev Med Pharmacol Sci; 2023 Oct; 27(19):9205-9212. PubMed ID: 37843334
[TBL] [Abstract][Full Text] [Related]
7. Transcriptionally active regions are the preferred targets for chromosomal HPV integration in cervical carcinogenesis.
Christiansen IK; Sandve GK; Schmitz M; Dürst M; Hovig E
PLoS One; 2015; 10(3):e0119566. PubMed ID: 25793388
[TBL] [Abstract][Full Text] [Related]
8. Aberrations in the mismatch repair genes and the clinical impact on oesophageal squamous carcinomas from a high incidence area in South Africa.
Naidoo R; Ramburan A; Reddi A; Chetty R
J Clin Pathol; 2005 Mar; 58(3):281-4. PubMed ID: 15735161
[TBL] [Abstract][Full Text] [Related]
9. Interactions among human papillomavirus proteins and host DNA repair factors differ during the viral life cycle and virus-induced tumorigenesis.
Wendel S; Wallace NA
mSphere; 2023 Dec; 8(6):e0042723. PubMed ID: 37850786
[TBL] [Abstract][Full Text] [Related]
10. Emerging role of mutations in epigenetic regulators including MLL2 derived from The Cancer Genome Atlas for cervical cancer.
Li X
BMC Cancer; 2017 Apr; 17(1):252. PubMed ID: 28390392
[TBL] [Abstract][Full Text] [Related]
11. The role of microsatellite instability in cervical intraepithelial neoplasia and squamous cell carcinoma of the cervix.
Wong YF; Cheung TH; Poon KY; Wang VW; Li JC; Lo KW; Yim SF; Yu MY; Lahr G; Chung TK
Gynecol Oncol; 2003 Jun; 89(3):434-9. PubMed ID: 12798708
[TBL] [Abstract][Full Text] [Related]
12. Microsatellite Instability as a Biomarker for PD-1 Blockade.
Dudley JC; Lin MT; Le DT; Eshleman JR
Clin Cancer Res; 2016 Feb; 22(4):813-20. PubMed ID: 26880610
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of DNA mismatch repair system in cervical dysplasias and invasive carcinomas related to HPV infection.
Kwaśniewska A; Goździcka-Józefiak A; Postawski K; Miturski R
Eur J Gynaecol Oncol; 2002; 23(3):231-5. PubMed ID: 12094961
[TBL] [Abstract][Full Text] [Related]
14. Gynecological Cancers Caused by Deficient Mismatch Repair and Microsatellite Instability.
Deshpande M; Romanski PA; Rosenwaks Z; Gerhardt J
Cancers (Basel); 2020 Nov; 12(11):. PubMed ID: 33182707
[TBL] [Abstract][Full Text] [Related]
15. FDA Approval Summary: Pembrolizumab for the Treatment of Microsatellite Instability-High Solid Tumors.
Marcus L; Lemery SJ; Keegan P; Pazdur R
Clin Cancer Res; 2019 Jul; 25(13):3753-3758. PubMed ID: 30787022
[TBL] [Abstract][Full Text] [Related]
16. The relationship between the PD-1/PD-L1 pathway and DNA mismatch repair in cervical cancer and its clinical significance.
Feng YC; Ji WL; Yue N; Huang YC; Ma XM
Cancer Manag Res; 2018; 10():105-113. PubMed ID: 29403308
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and Safety of Pembrolizumab in Previously Treated Advanced Cervical Cancer: Results From the Phase II KEYNOTE-158 Study.
Chung HC; Ros W; Delord JP; Perets R; Italiano A; Shapira-Frommer R; Manzuk L; Piha-Paul SA; Xu L; Zeigenfuss S; Pruitt SK; Leary A
J Clin Oncol; 2019 Jun; 37(17):1470-1478. PubMed ID: 30943124
[TBL] [Abstract][Full Text] [Related]
18. Frequency of Mismatch Repair Deficiency/High Microsatellite Instability and Its Role as a Predictive Biomarker of Response to Immune Checkpoint Inhibitors in Gynecologic Cancers.
Noh JJ; Kim MK; Choi MC; Lee JW; Park H; Jung SG; Joo WD; Song SH; Lee C
Cancer Res Treat; 2022 Oct; 54(4):1200-1208. PubMed ID: 34902958
[TBL] [Abstract][Full Text] [Related]
19. Genetics and beyond: Precision Medicine Real-World Data for Patients with Cervical, Vaginal or Vulvar Cancer in a Tertiary Cancer Center.
Kraus FBT; Sultova E; Heinrich K; Jung A; Westphalen CB; Tauber CV; Kumbrink J; Rudelius M; Klauschen F; Greif PA; König A; Chelariu-Raicu A; Czogalla B; Burges A; Mahner S; Wuerstlein R; Trillsch F
Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38397025
[TBL] [Abstract][Full Text] [Related]
20. Microsatellite instability and chemosensitivity in solid tumours.
Cherri S; Oneda E; Noventa S; Melocchi L; Zaniboni A
Ther Adv Med Oncol; 2022; 14():17588359221099347. PubMed ID: 35620236
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
